Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | ATM | Q13315 | 1/20 | 0.67 |
| ▸ | WHR1 | P49842 | 1/20 | 0.57 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | NR1I3 | Q14994 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.50 |
| ▸ | AHR | P35869 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | VDR | P11473 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18503958 | 0.96 | MEN1 (0.63) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL18504010 | 0.95 | MEN1 (0.61) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL18503954 | 0.95 | MEN1 (0.66) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL24084022 | 0.95 | MEN1 (0.66) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL24084045 | 0.95 | MEN1 (0.61) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL12014869 | 0.94 | MEN1 (0.69) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL31065527 | 0.93 | MEN1 (0.59) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL18504016 | 0.93 | MEN1 (0.64) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL24084040 | 0.93 | MEN1 (0.58) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL23606772 | 0.93 | MEN1 (0.68) | MEN1KMT2AATMWHR1NUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1947707-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIQUID CRYSTAL DISPLAY DEVICE, AND LIGHTING EQUIPMENT | KONICA MINOLTA HOLDINGS INC (JP) | 2017-04-26 | — | — | EP | disclosed |
| EP-2651904-B1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2014-11-12 | — | — | EP | disclosed |
| US-8362246-B2 | Bispyrimidines for electronic applications | BASF SE (DE) | 2013-01-29 | — | — | US | disclosed |
| US-8362246-B2 | Bispyrimidines for electronic applications | BASF SE (DE) | 2013-01-29 | — | — | US | disclosed |
| US-8310146-B2 | Organic electroluminescent device, liquid crystal display and illuminating device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-11-13 | — | — | US | disclosed |
| US-8310146-B2 | Organic electroluminescent device, liquid crystal display and illuminating device | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-11-13 | — | — | US | disclosed |
| WO-2012080052-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-06-21 | — | — | WO | disclosed |
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-06-14 | — | — | US | disclosed |
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-06-14 | — | — | US | disclosed |
| US-20090279285-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, LIQUID CRYSTAL DISPLAY AND ILLUMINATING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090279285-A1 | ORGANIC ELECTROLUMINESCENT DEVICE, LIQUID CRYSTAL DISPLAY AND ILLUMINATING DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2009-11-12 | — | — | US | disclosed |
| EP-1947707-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIQUID CRYSTAL DISPLAY DEVICE, AND LIGHTING EQUIPMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2008-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | DPYD, TYMP, TYMS | MEN1 3376/4885KMT2A 2215/4885ATM 2950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.